HIV & AIDS

New blood spot test used internationally in fight against HIV

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz have developed a technique that estimates an HIV-negative patient's adherence to drugs prescribed to prevent HIV transmission during ...

Medications

Harms reporting in trials of orlistat

The reporting of trials of orlistat in the 1990s appears to have understated harms, both in the summarized results submitted to the European Medicines Agency for drug approval, and in the published papers, according to a ...

Medications

Advocates hope shaming drugmakers discourages price spikes

Frustrated by the rising cost of prescription drugs, California health advocates hope sunlight and a dose of shame will discourage drugmakers from raising their prices too quickly or introducing new medications at prices ...

Medications

Teva stops selling migraine patch after reports of burns

Teva Pharmaceutical said Monday that it will stop selling its migraine patch treatment Zecuity after users reported burns and scars where it was applied. The company advised that anyone who has its patch should not use it.

Medications

FDA approves cinqair for severe asthma

(HealthDay)—Cinqair (reslizumab) has been approved by the U.S. Food and Drug Administration to treat severe asthma among adults 18 and older.

Medications

France to call for lower drug prices at G7

France will announce a campaign to lower the price of new medicines, hoping world powers at the upcoming G7 meeting will put pressure on the pharmaceutical industry, its health minister said Tuesday.

page 37 from 40